SURREY, BC / ACCESSWIRE / December 22, 2021 / American Manganese Inc. (TSXV:AMY)(OTCQB:AMYZF)(FSE:2AM) ("AMY" or the "Company") is pleased to share a year-end review of the significant company highlights that have been fundamental in strategically positioning American Manganese for the new year.

Lithium-ion Battery Cathode Recycling (RecycLiCo) Highlights:

Achieved successful recycling and upcycling of lithium-ion battery black mass and production scrap into NMC532, NMC622, and NMC811 cathode precursor and sent samples to third parties for product validation

Achieved successful production of 99.99% pure lithium sulfate, from waste battery material, and sent samples to third parties for product validation

Began modelling, design, and preparation of the RecycLiCo demonstration plant

Signed Memorandum of Understanding with Italvolt SpA to develop commercial recycling plant alongside Italvolt's planned Gigafactory in Scarmagno, Italy

Received advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support a pilot project, entitled, 'Demonstration of Continuous Recycling of Cathode Material from Lithium-ion Battery Production Scrap'

Awarded Solar Impulse Efficient Solution Label, an initiative by the Solar Impulse Foundation to select solutions that meet high standards in profitability and sustainability

Technical battery recycling papers published in the Journal of the Electrochemical Society and International Journal of Green Energy

Issued patents in South Korea, Japan, India and received a patent ‘notice of allowance' in Canada

Wenden Stockpile Reclamation and Advanced Material Processing Project Highlights:

Completed and submitted all identified milestones in the U.S. Defense Logistics Agency (DLA) awarded project to perform work on the United States Government's manganese stockpile located near Wenden, Arizona

Achieved 99% manganese extraction results and produced electrolytic manganese metal (EMM) from Wenden Stockpile material.

Closed brokered private placement for gross proceeds of C$20 million. The Company issued up to 20,000,000 Common Shares at a purchase price of C$1.00 per and associated Warrant at a purchase price of C$1.25.

Received approximately $6,000,000 from the exercise of issued warrants and options

"We have had an incredible year on multiple fronts and laid a strong foundation for the company to continue to grow and innovate in 2022. The RecycLiCo and Wenden projects have demonstrated their added value and differentiation in the market, and we have a unique opportunity to be involved in shifting trends and a growing market focused on cleantech and critical battery metals. Our financing highlights also represent an important milestone that enhances our ability to execute on our growth strategy," said Larry Reaugh, President and CEO of American Manganese. "Thank you to our team and shareholders for a great year. Have a happy holiday season and a prosperous new year."

American Manganese Inc. is a critical metals company focused on recycling and upcycling lithium-ion battery waste into high-value battery cathode materials, using its closed-loop RecycLiCo™ process. With minimal processing steps and over 99% extraction of lithium, cobalt, nickel, and manganese, the upcycling process creates valuable lithium-ion battery materials for direct integration into the re-manufacturing of new lithium-ion batteries.

On behalf of Management AMERICAN MANGANESE INC.

Larry W. Reaugh President and Chief Executive Officer Telephone: 778 574 4444 Email: lreaugh@amymn.com

www.americanmanganeseinc.com www.recyclico.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain "forward-looking statements", which are statements about the future based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements by their nature involve risks and uncertainties, and there can be no assurance that such statements will prove to be accurate or true. Investors should not place undue reliance on forward-looking statements. The Company does not undertake any obligation to update forward-looking statements except as required by law.

View source version on accesswire.com: https://www.accesswire.com/679045/American-Manganese-Reviews-2021-Highlights

Dow Jones futures tilted higher Sunday night, along with S&P 500 futures and Nasdaq futures. The stock market rally revived last week, with the S&P 500 nearly at a new high while a diverse list of leaders flashed buy signals, including AMD stock and Google parent Alphabet.

Naren Gupta, a venture capitalist who co-founded Nexus Venture Partners to help plant Indian SaaS startups on the world map, died on Saturday. Gupta, who moved to the U.S. to pursue higher education in late 1960s, co-founded Integrated Systems, a software firm that was ultimately sold to Intel. After leaving the firm, Gupta began exploring investment opportunities.

Skyworks Solutions (NASDAQ: SWKS) and Chewy (NYSE: CHWY) haven't been the best performers in 2021, as shares of both companies have dipped despite terrific growth in their businesses. Let's look at the reasons why Skyworks Solutions and Chewy could go on a bull run and leave this year's disappointing performance behind. Skyworks Solutions stock has dipped of late thanks to speculation that the demand for Apple's (NASDAQ: AAPL) iPhone would take a hit in the holiday season.

When looking for investment ideas for 2022, it pays to look at those stocks that have beaten the market in 2021. Savvy investors know that winners tend to keep on winning, so picking stocks that are already in the market-beating category can increase your odds of investing success.

(Bloomberg) -- Asian stocks were mixed and U.S. equity futures were steady Monday amid a mood of caution as traders evaluated spiking coronavirus cases and a weekend pledge of greater economic support from China’s central bank.Most Read from BloombergCoronavirus Can Persist for Months After Traversing BodyCases Surge Globally; Fauci Warns of Complacency: Virus UpdateChina Reports Most Daily Local Infection Cases Since JanuaryWorld Economy Now Set to Surpass $100 Trillion in 2022Alex Jones' Wife

Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?

The dividends for such stocks are pretty much their only attraction. On the other hand, you can find dividend stocks that are anything but boring and stodgy. Here are three dividend stocks that soared more than 50% in 2021 and are still great buys.

SAND and MANA are two of the leading projects in the metaverse space at the moment, and their positive momentum could extend into the coming year.

Abbott Laboratories (NYSE: ABT) shares have gained around 26% in 2021. Despite the big payout bumps, Abbott only needed around 33% of the free cash flow its operations generated over the past year to make dividend payments. Despite pandemic pressure, medical-device segment sales during the first nine months of 2021 rose 24.5% year over year to $10.6 billion.

We’re about to turn the page on the calendar, put 2021 behind us, and stride into the brave, new year of 2022 – and Wall Street’s prognosticators are busy scanning the stocks to find the winners and losers for next year’s markets. Whether it’s individual stocks, whole industry sectors, or some combination of both, the analysts are finding plenty of Buy-rated equities for investors to consider. Take the automotive sector. Few industrials will present as many investment opportunities, both in 2022

Wall Street's consensus price target for Teladoc Health (NYSE: TDOC) stock over the next 12 months reflects a 67% upside potential. It's quite possible that the spread of the omicron variant of COVID-19 could give Teladoc a boost in the near term. Teladoc enjoyed a big surge in virtual visits in 2020 thanks to the pandemic.

Hundreds of Chinese companies are listed on U.S. markets. But which are the best Chinese stocks to buy or watch right now? JD.com , Nio, Li Auto, Xpeng and BYD Co.. China is the world's most-populous nation and the second-largest economy with a booming urban middle class and amazing entrepreneurial activity.

Will SPY continue the bull run in 2022 after the FED announced it will accelerate the reduction of its monthly bond purchases?

MP Materials director Randall Weisenburger bought $3.5 million of shares. MP has a deal to provide General Motors with rare-earth magnets.

(Bloomberg) -- The head of Norway’s $1.4 trillion wealth fund said he expects a lengthy period of weakness in financial markets and warned that inflation could be the most significant challenge ahead.Most Read from BloombergCoronavirus Can Persist for Months After Traversing BodyCases Surge Globally; Fauci Warns of Complacency: Virus UpdateChina Reports Most Daily Local Infection Cases Since JanuaryWorld Economy Now Set to Surpass $100 Trillion in 2022Alex Jones' Wife Arrested on Domestic Violen

Boeing recorded 109 737 Max orders in November and some 767 freighter orders in December. Is Boeing stock a good buy now?

As traders return from last week's holiday-shortened week, the price action heading into the new year will be closely monitored, especially given the relatively light economic data and earnings calendar for the coming days.

(Bloomberg) -- A world-beating share rally by a Thai technology company after it unveiled an expansion into Bitcoin mining has surprised even the firm’s chairman. Most Read from BloombergCoronavirus Can Persist for Months After Traversing BodyCases Surge Globally; Fauci Warns of Complacency: Virus UpdateChina Reports Most Daily Local Infection Cases Since JanuaryWorld Economy Now Set to Surpass $100 Trillion in 2022Alex Jones' Wife Arrested on Domestic Violence ChargeJasmine Technology Solution

Some savers may want to 'double-up,' if you will and buy I Bonds before year end. Inflation-indexed savings bonds gain more interest as prices go up.

There's no denying that 2021 has been a rough year for many biotech stocks. The shares of quite a few big and small biotech companies alike are set to finish the year in negative territory. Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Novartis (NYSE: NVS), and Vertex Pharmaceuticals (NASDAQ: VRTX).